These findings collectively demonstrate a potential role of HSP90α in the pathogenesis of AP, possibly through its interaction with the NLRP3 inflammasome, suggesting its potential as a novel therapeutic agent for AP treatment. Here, NLRP3 is linked to alkaline phosphatase measurement.